An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6

This publication has 24 references indexed in Scilit:

• Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway
  The American Journal of Pathology, 2003
• Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth
  Molecular and Cellular Endocrinology, 2002
• Interleukin-6 Is an Autocrine Growth Factor in Human Prostate Cancer
  The American Journal of Pathology, 2001
• Vascular Endothelial Growth Factor-Mediated Autocrine Stimulation of Prostate Tumor Cells Coincides with Progression to a Malignant Phenotype
  The American Journal of Pathology, 2001
• Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
  Urology, 1999
• Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
  Nature, 1998
• Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS–Kaposi sarcoma
  Proceedings of the National Academy of Sciences, 1997
• Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6
  International Journal of Cancer, 1996
• Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
  Journal of Biological Chemistry, 1996
• Interleukin-6: A candidate mediator of human prostate cancer morbidity
  Urology, 1995